Michael J. Blankinship, Ph.D.
Affiliations: | 2005 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
muscle gene therapy, DMDGoogle:
"Michael Blankinship"Parents
Sign in to add mentor| Jeffrey Chamberlain | grad student | 2005 | University of Michigan | |
| (Advances in recombinant adeno -associated virus technology and implications for the treatment of Duchenne muscular dystrophy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blankinship MJ, Gregorevic P, Allen JM, et al. (2009) Erratum to "Efficient Transduction of Skeletal Muscle Using Vectors Based on Adeno-associated Virus Serotype 6". Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1482 |
| Gregorevic P, Schultz BR, Allen JM, et al. (2009) Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1427-33 |
| Davis J, Westfall MV, Townsend D, et al. (2008) Designing heart performance by gene transfer. Physiological Reviews. 88: 1567-651 |
| Gregorevic P, Blankinship MJ, Allen JM, et al. (2008) Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 657-64 |
| Gregorevic P, Meznarich NA, Blankinship MJ, et al. (2008) Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping. Muscle & Nerve. 37: 104-6 |
| Townsend D, Blankinship MJ, Allen JM, et al. (2007) Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1086-92 |
| Wang Z, Kuhr CS, Allen JM, et al. (2007) Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1160-6 |
| Salva MZ, Himeda CL, Tai PW, et al. (2007) Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 320-9 |
| Gregorevic P, Allen JM, Minami E, et al. (2006) rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nature Medicine. 12: 787-9 |
| Blankinship MJ, Gregorevic P, Chamberlain JS. (2006) Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 241-9 |